Important pharmacy news and late-breaking industry information updated daily.

Hawaii on Tuesday became the first state in the nation to begin enacting ban on the sale of sunscreens containing coral-harming chemicals. The chemicals, oxybenzone and octinoxate, are believed by scientists to be toxic to coral reefs. These chemicals are in the majority of sunscreen products.

With a vote of 14-3, two FDA advisory committees have voted against recommending approval of abuse-deterrent (AD) oxycodone extended-release capsules (Remoxy ER—Pain Therapeutics) for severe pain.

Amazon is buying online pharmacy PillPack Inc. giving the e-commerce giant the ability to ship prescriptions around the country, and making it a direct threat to the more than $400 billion pharmacy business. Amazon is reportedly paying approximately $1 billion in cash for PillPack.

FDA Commissioner Scott Gottlieb said the "easy availability of opioids online" has become "a major public health concern," as federal regulators increased pressure on major internet firms to do more to prevent such sales. Internet industry leaders met with government officials at a summit meeting Wednesday.

Rite Aid has issued a letter to its shareholders highlighting the merits of its proposed merger with Albertsons, in an effort to gain shareholder approval for the $24 billion deal at an August 9 special shareholder meeting. The letter cites the merger's potential to grow the company’s scale and diversity its business.

Cannabidiol drug approved for use in two forms of epilepsy

Theresa Tolle emphasized pharmacists’ role in containing costs for patients

FDA approved on Monday cannabidiol (Epidiolex—GW Research Ltd.) oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome—two rare and severe forms of epilepsy—in patients aged 2 years and older.

Research may nudge asthma guideline update

Pharmacists can discuss with suppliers and map projections to patient needs